Position history for BlackRock, Inc.'s holdings in TAYSHA GENE THERAPIES INC
BlackRock, Inc. holds 18.4M shares of TSHA (TAYSHA GENE THERAPIES INC), worth $82.1M as of 2026-Q1. The position was decreased (-1.5% shares). TSHA represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$82.1M
Current Shares
18.4M
Total Value Change
+$58.7M
Total Shares Change
+4.8M
Other major holders of TSHA: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, GOLDMAN SACHS GROUP INC
Decreased |
| 18.4M |
-1.5% |
| $82.1M |
| 0.0% |
| $4.53 |
0 |
| 2025-Q4 | Increased | 18.6M | +13.9% | $102.5M | 0.0% | $5.66 | 34 |
| 2025-Q3 | Increased | 16.4M | +23.0% | $53.5M | 0.0% | $3.16 | 36 |
| 2025-Q2 | Decreased | 13.3M | -2.1% | $30.7M | 0.0% | $2.38 | 0 |
| 2025-Q1 | Increased | 13.6M | +0.4% | $18.9M | 0.0% | $1.93 | 28 |
| 2024-Q4 | New | 13.5M | - | $23.4M | 0.0% | $1.73 | 40 |